1. Antibody fragments structurally enable a drug‐discovery campaign on the cancer target Mcl‐1. Issue 11 (6th November 2019) Authors: Luptak, Jakub; Bista, Michal; Fisher, David; Flavell, Liz; Gao, Ning; Wickson, Kate; Kazmirski, Steven L.; Howard, Tina; Rawlins, Philip B.; Hargreaves, David Journal: Acta crystallographica Issue: Volume 75:Issue 11(2019) Page Start: 1003 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease. Issue 1 (December 2017) Authors: Rueda, Fernando; Bista, Michal; Newton, Matthew; Goeppert, Anne; Cuomo, M. Emanuela; Gordon, Euan; Kröner, Felix; Read, Jon; Wrigley, Jonathan; Rueda, David; Taylor, Benjamin Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1. (February 2019) Authors: Shaw, Joseph; Dale, Ian; Hemsley, Paul; Leach, Lindsey; Dekki, Nancy; Orme, Jonathan P.; Talbot, Verity; Narvaez, Ana J.; Bista, Michal; Martinez Molina, Daniel; Dabrowski, Michael; Main, Martin J.; Gianni, Davide Journal: SLAS discovery Issue: Volume 24:Number 2(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Quantifying the relationship between inhibition of VEGF receptor 2, drug‐induced blood pressure elevation and hypertension. (18th January 2018) Authors: Collins, Teresa; Gray, Kelly; Bista, Michal; Skinner, Matt; Hardy, Christopher; Wang, Haiyun; Mettetal, Jerome T; Harmer, Alexander R Journal: British journal of pharmacology Issue: Volume 175:Number 4(2018) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗